Simulations Plus has recently declined after its Q3 2025 report, despite having a healthy revenue growth and adjusted EPS beat. This decline was mostly driven by a non‑cash impairment and lowered ...

Simulations Plus is a specialized in silico software-and-services platform. They help with model-informed, non-animal drug development. SLP’s services help across discovery, development, and clinical ...

Wahbi El-Bouri receives funding from The Royal Society and EPSRC. He is affiliated with the Avicenna Alliance and InSilico UK communities that seek to drive adoption of in silico clinical trials for ...

Chemical and biochemical processes can be modeled in silico based on knowledge of the molecular structure of the species involved and understanding basic chemical interactions, allowing such processes ...

丙烯酰胺通过多靶点相互作用和通路调控发挥毒性，其高水溶性和胃肠道吸收性增强生物利用度，但无法穿透血脑屏障。计算和生物信息学分析显示，68个共同靶点形成PPI网络，其中AKT1、TP53、BCL2为关键枢纽基因，涉及DNA修复、细胞存活和氧化应激等通路。

AUSTIN, Texas and TOKYO, Nov. 27, 2025 /PRNewswire/ -- According to DataM Intelligence, the In-Silico Clinical Trials Market Size was USD 3.76 billion in 2023, increased to USD 3.95 billion in 2024, ...

MORRISVILLE, N.C. and MILAN and TRIESTE, Italy , March 13, 2023 /PRNewswire/ -- Premier Research, whose mission is to help the most innovative biotech and device companies take their best ideas from ...